Annette Wundes

1.2k total citations
35 papers, 813 citations indexed

About

Annette Wundes is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Annette Wundes has authored 35 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 8 papers in Neurology. Recurrent topics in Annette Wundes's work include Multiple Sclerosis Research Studies (23 papers), Polyomavirus and related diseases (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Annette Wundes is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Polyomavirus and related diseases (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Annette Wundes collaborates with scholars based in United States, Germany and United Kingdom. Annette Wundes's co-authors include James D. Bowen, Halvard Bönig, Sylvia Lucas, Kai-Hsin Chang, Thalia Papayannopoulou, George H. Kraft, Harry Openshaw, Richard A. Nash, Douglas L. Arnold and Uday Popat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Annette Wundes

34 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Wundes United States 15 547 265 161 157 148 35 813
Aurora Zanghì Italy 16 462 0.8× 174 0.7× 132 0.8× 169 1.1× 63 0.4× 50 648
M. Stojanovic Serbia 8 815 1.5× 271 1.0× 241 1.5× 361 2.3× 78 0.5× 18 1.0k
Lisa Costelloe Ireland 11 483 0.9× 191 0.7× 485 3.0× 134 0.9× 77 0.5× 15 1.0k
Carrie M. Hersh United States 13 465 0.9× 135 0.5× 61 0.4× 150 1.0× 51 0.3× 51 588
Julia O’Mahony Canada 16 589 1.1× 102 0.4× 149 0.9× 325 2.1× 79 0.5× 43 840
Ryan Ramanujam Sweden 14 472 0.9× 141 0.5× 180 1.1× 185 1.2× 43 0.3× 27 804
Pierangelo Barbero Italy 15 623 1.1× 259 1.0× 134 0.8× 408 2.6× 77 0.5× 34 951
Paul O’Connor Canada 11 926 1.7× 284 1.1× 220 1.4× 329 2.1× 99 0.7× 22 1.1k
T. Pickersgill United Kingdom 8 582 1.1× 141 0.5× 193 1.2× 253 1.6× 36 0.2× 12 730
Augusto Miravalle United States 10 412 0.8× 208 0.8× 132 0.8× 155 1.0× 34 0.2× 28 629

Countries citing papers authored by Annette Wundes

Since Specialization
Citations

This map shows the geographic impact of Annette Wundes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Wundes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Wundes more than expected).

Fields of papers citing papers by Annette Wundes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Wundes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Wundes. The network helps show where Annette Wundes may publish in the future.

Co-authorship network of co-authors of Annette Wundes

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Wundes. A scholar is included among the top collaborators of Annette Wundes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Wundes. Annette Wundes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamudoni, Paul, Dagmar Amtmann, Jeffrey Johns, et al.. (2024). People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summary. Neurodegenerative Disease Management. 14(5). 119–125. 1 indexed citations
2.
Wang, Yujie, et al.. (2023). Case Series of Patients with Brainstem Inflammation Causing Paroxysmal Movement Disorders (P4-5.016). Neurology. 100(17_supplement_2). 2 indexed citations
3.
Kamudoni, Paul, Dagmar Amtmann, Jeffrey Johns, et al.. (2022). The validity, responsiveness, and score interpretation of the PROMISnq Physical Function – Multiple Sclerosis 15a short form in multiple sclerosis. Multiple Sclerosis and Related Disorders. 62. 103753–103753. 7 indexed citations
4.
Wray, Sibyl, Florian Then Bergh, Annette Wundes, et al.. (2022). Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study. Advances in Therapy. 39(4). 1810–1831. 26 indexed citations
5.
Kamudoni, Paul, Jeffrey Johns, Karon F. Cook, et al.. (2021). Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 – Fatigue (MS) 8a. Multiple Sclerosis and Related Disorders. 54. 103117–103117. 16 indexed citations
6.
Mehta, Dev, et al.. (2021). Perforated diverticulitis associated with ocrelizumab infusion. 1. 100013–100013. 4 indexed citations
7.
Alschuler, Kevin N., Daniel Whibley, Anna L. Kratz, et al.. (2021). Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndrome. Journal of Neurology. 269(5). 2560–2572. 1 indexed citations
8.
9.
Alschuler, Kevin N., Gloria von Geldern, Kathleen Costello, et al.. (2020). Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS. Multiple Sclerosis and Related Disorders. 46. 102600–102600. 2 indexed citations
10.
Naismith, Robert T., Jerry S. Wolinsky, Annette Wundes, et al.. (2019). Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Multiple Sclerosis Journal. 26(13). 1729–1739. 47 indexed citations
11.
Georges, George E., Peter A. McSweeney, James D. Bowen, et al.. (2018). Autologous Hematopoietic Stem Cell Transplantation May Be Highly Effective Treatment for Severe, Treatment Refractory Stiff Person Syndrome (S31.007). Neurology. 90(15_supplement). 4 indexed citations
12.
Gallagher, Lisa G., Sindana D. Ilango, Annette Wundes, et al.. (2018). Lifetime exposure to ultraviolet radiation and the risk of multiple sclerosis in the US radiologic technologists cohort study. Multiple Sclerosis Journal. 25(8). 1162–1169. 14 indexed citations
13.
Ehde, Dawn M., Kevin N. Alschuler, Mark D. Sullivan, et al.. (2017). Improving the quality of depression and pain care in multiple sclerosis using collaborative care: The MS-care trial protocol. Contemporary Clinical Trials. 64. 219–229. 15 indexed citations
14.
Wundes, Annette, et al.. (2016). Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay. Neurology. 86(5). 484–486. 31 indexed citations
15.
Bowen, James D., George H. Kraft, Annette Wundes, et al.. (2011). Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results. Bone Marrow Transplantation. 47(7). 946–951. 59 indexed citations
16.
Wundes, Annette, George H. Kraft, James D. Bowen, Ted Gooley, & Richard A. Nash. (2010). Mitoxantrone for worsening multiple sclerosis: Tolerability, toxicity, adherence and efficacy in the clinical setting. Clinical Neurology and Neurosurgery. 112(10). 876–882. 10 indexed citations
17.
Wundes, Annette, Theodore R. Brown, E. Jay Bienen, & Craig I Coleman. (2010). Contribution of intangible costs to the economic burden of multiple sclerosis. Journal of Medical Economics. 13(4). 626–632. 26 indexed citations
18.
Bönig, Halvard, Annette Wundes, & Thalia Papayannopoulou. (2008). Response: More about multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors. Blood. 112(1). 209–210. 2 indexed citations
19.
Bönig, Halvard, Annette Wundes, Kai-Hsin Chang, Sylvia Lucas, & Thalia Papayannopoulou. (2007). Hematopoietic Stem/Progenitor Cells (HSPC) Mobilization Parameters in Patients Chronically Treated with the CD49d Blocking Antibody Natalizumab.. Blood. 110(11). 177–177. 1 indexed citations
20.
Bönig, Halvard, Annette Wundes, Jens Verheyen, et al.. (2000). In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors. Bone Marrow Transplantation. 26(1). 91–96. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurora Zanghì Breakdown of academic impact, for papers by M. Stojanovic Breakdown of academic impact, for papers by Lisa Costelloe Breakdown of academic impact, for papers by Carrie M. Hersh Breakdown of academic impact, for papers by Julia O’Mahony Breakdown of academic impact, for papers by Ryan Ramanujam Breakdown of academic impact, for papers by Pierangelo Barbero Breakdown of academic impact, for papers by Paul O’Connor Breakdown of academic impact, for papers by T. Pickersgill Breakdown of academic impact, for papers by Augusto Miravalle
Rankless by CCL
2026